Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® C. Difficile specialty page provides c. difficile-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

C. DIFFICILE NEWS - Page 6

Changing the Incidence of <em>Clostridium difficile</em> Through Patient Hand Hygiene
C. difficile prevention is usually thought of in terms of environmental disinfection and health care worker hand hygiene; what about the patient's role?
Top 5 <i>Contagion</i>® News Articles for the Week of October 8, 2017
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Higher Antibiotic Use & <i>C. diff</i> Rates Found After Sepsis Program Implementation
A recent study found that a sepsis care bundle program implemented in The Mount Sinai Hospital in New York coincided with an increase in antibiotic prescriptions and higher rates of Clostridium difficile infections.
Nearly 10% of Americans with Candidemia have <em>Clostridium difficile</em> Co-infection
The message for clinicians is to be vigilant. Look for candidemia and C. difficile infection occurring together.
Tetracyclines Associated with Lower Risk of CDI
A recent study has shown that, compared with other antibiotics, tetracyclines may be associated with a reduced risk of Clostridium difficile infection (CDI).
Ribaxamase Found to Prevent New Onset <em>Clostridium difficile</em> Infections
About 500,000 Americans fall ill from Clostridium difficile infections every year.
Antibiotics Prescribed by Dentists May Be Contributing to CDI Incidence
Dr. Maria Bye, an epidemiologist at the Minnesota Department of Health shares some unsettling news when it comes to C. difficile: dentists’ prescribing habits may be contributing to CDI incidence.
Narrow-Spectrum Antibiotic for <em>C. Difficile</em> Fails to Show Treatment Benefit Over Vancomycin
Surotomycin fails to show benefit over vancomycin for the treatment of Clostridium difficile infection in a phase 3 trial.
FEATURED
Big advances in treatment can